期刊文献+

Neu-P11减少大鼠睡眠潜伏期增加睡眠时间 被引量:3

Neu-P11 Reduces Sleep Latency and Increases Sleep Length in the Multiple Sleep Latencies Test in Rats
下载PDF
导出
摘要 目的基于多次睡眠潜伏期测试方法,检测一种新颖的褪黑素受体激动剂Neu-P11对大鼠睡眠潜伏期和睡眠时间的影响。方法大鼠多次睡眠潜伏期测试包括习惯化与检测两个阶段,两者间隔24 h。检测阶段包括总共3 h内的6个单个测试,单个测试时间是30 min;在每个单个测试中,先呈现5 min的干扰声刺激,之后25 min不呈现干扰声刺激。根据视频录像分析大鼠在25 min内入睡所需的时间(睡眠潜伏期)和睡眠时间。在检测之前6~8 min腹腔注射Neu-P11(5、10、20和50 mg/kg)或等体积溶媒。结果与溶媒组大鼠比较,Neu-P11(20和50 mg/kg)处理组大鼠其睡眠潜伏期显著性减少而睡眠时间显著性增加。结论在大鼠多次睡眠潜伏期测试中,Neu-P11可通过减少睡眠潜伏期增加睡眠时间,最终改善睡眠。 Objective To assess the effects of a novel melatonin agonist Neu-P11 on the sleep latency and sleep length in the rat multiple sleep latencies test(MSLT).Methods The MSLT included six separate sleep latency trails conducted within 3 h(30 min per trial).For each trail,the rats were initially kept awake for 5 min by means of gentle handling,and then were left undisturbed for 25 min.The time to fall asleep(sleep latency)and sleep length within the undisturbed 25 min period were recorded.The rMSLT was run 6~8 min after Neu-P11(5,10,20 and 50 mg/kg)was administrated.Results Compared with vehicle group,both the groups with Neu-P11 at 20 and 50 mg/kg showed a significant less level of sleep latency.At the same time,both the groups with Neu-P11 at 20 and 50 mg/kg,compared with vehicle group,showed a significant more level of sleep length.Conclusion Neu-P11 improves sleep by reducing sleep latency and increasing sleep length in the MSLT in rats.
出处 《中南医学科学杂志》 CAS 2011年第2期156-159,共4页 Medical Science Journal of Central South China
基金 国家自然科学基金(30770689) 湖南省自然科学基金重点项目(10JJ2009) 以色列Neurim Pharmaceuticals公司研究基金 湖南省教育厅一般项目(09C831)
关键词 Neu-P11 褪黑素 多次睡眠潜伏期测试 睡眠 大鼠 Neu-P11 melatonin multiple sleep latencies test sleep rat
  • 相关文献

参考文献1

二级参考文献63

  • 1Wong ML, LicinioJ. Research and treatment approaches to depression. Nat Rev Neurosci 2001; 2: 343-51.
  • 2Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et el. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003; 64: 1465-75.
  • 3Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep 2000; 48: 1-106.
  • 4Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11-53.
  • 5Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155: 4-11.
  • 6Lenox RH, Frazer A. Mechanism of action of antidepressants and mood stabilizers. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Williams & Wilkins; 2002. p 1139-63.
  • 7Nash J, Nutt D. Antidepressants. Psychiatry 2007; 6: 289-94.
  • 8Hudson JL, Gradisar M, Gamble A, Schniering CA, Rebelo I. The sleep patterns and problems of clinically anxious children. Behav Res Ther 2009; 47: 339-44.
  • 9Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poe-eler B, et al. Pathophysiology of depression: role of sleep and the melatonergic system. Psychiat Res 2009; 165: 201-14.
  • 10Takeuchi T, Nakao M, Nomura K, Yano E. Association of metabolic syndrome with depression and anxiety in Japanese men. Diabetes Metab 2009; 35: 32-6.

共引文献10

同被引文献33

  • 1徐峰,李经才,张杨,张倩,刘永刚,罗景慧,王暖.褪黑素的抗应激作用[J].沈阳药科大学学报,1996,13(1):18-23. 被引量:27
  • 2张石革,梁建华.催眠药的发展趋势与合理应用[J].中国全科医学,2007,10(2):137-139. 被引量:7
  • 3She M,Deng X,Guo Z,et al. Neu-P11, a novel melatonin ago- nist, inhibits weight gain and improves insulin sensitivity in hishfat/hish-sucrose-fed rats [ J ]. Pharmacologica! Research, 2009,59(4) : 248 -253.
  • 4Lenoir V,de Jonage-Canonico M B, Perrin M H, et al. Preven- tive and curative effect of melatonin on mammary carcinogene- sis induced by dinethybenz[ a] anthracene in the female Spra- gue - Daw - Icy rat [ J]. Breast Cancer Research, 2005, 7 (4): 470-476.
  • 5Pieri C, Marra M, Moroni F, et al. Melatonin: a peroxyl radicalscavenger more effective than vitamin E [ J]. Life sci, 1994, 55(15) : 271 -276.
  • 6Russel J. Melatonin reduces oxidant damage and promotes mito- chondrial respiration [ J ]. New York Academy of Sciences, 2002, 959 : 238 - 256.
  • 7Negrette B, Bonilla E, Valero N, et al. Melatonin Treatment En- hances the Efficiency of Mice Immunization with Enezuelan E- quine Encephalomyelitis Virus TC - 83 [ J ]. Neurochem Res, 2001,26(7): 767 -770.
  • 8Osawa H,Onuma H, Ochi M, et al. SNP - 420 determines its monocyte mRNA and serum levels inducing type 2 diabetes [J]. Biochem Biophys Res Commun, 2005, 335 (2): 596- 602.
  • 9Weiss R. Fat distribution and storage : how much, where, and how? [J]. Eur J Endocrinol, 2007, 157:39-45.
  • 10许欢妮.褪黑素及其受体激动剂对脂肪细胞胰岛素抵抗相关因子影响的研究[D].中国优秀博硕士学位论文全文数据库(硕士)南华大学,2010:6-12.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部